Hobbs Group Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-281
Closed -$14.5K 204
2024
Q3
$14.5K Sell
281
-1
-0.4% -$47 0.01% 386
2024
Q2
$11.7K Buy
+282
New +$12.6K ﹤0.01% 373
2023
Q4
$67.1K Buy
+1,308
New +$68.7K 0.03% 185

Other funds holding BMY

Hobbs Group Advisors's BMY Position: Q4 2024 in Review

Hobbs Group Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 281 shares — an estimated $14.5K sold.

Hobbs Group Advisors first reported a position in BMY in Q4 2023 and held it in 3 quarters. The position peaked at $67.1K in Q4 2023. 2,494 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Hobbs Group Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • Hobbs Group Advisors sold 281 Bristol-Myers Squibb shares in Q4 2024, an estimated $14.5K.
  • Hobbs Group Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 3 quarters.
  • Hobbs Group Advisors's Bristol-Myers Squibb position peaked at $67.1K in Q4 2023.
  • 2,494 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Hobbs Group Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.